Company attributes
Location
B2X
Founder
Pitchbook URL
Number of Employees (Ranges)
11 – 50
Email Address
rznomics@rznomics.com0
Full Address
327 152 Jukjeon-ro, Suji-gu, Gyeonggi Yongin-si South Korea0
#801, #803 Innovalley Bldg. C, 253, Pangyo-ro, Bundang-gu, Seongnam, 13486, Korea0
Investors
Founded Date
August 2017
Total Funding Amount (USD)
2,691,043
Latest Funding Round Date
October 2019
Latest Funding Type
Patents Assigned (Count)
1
Country
Other attributes
Company Operating Status
Active
Rznomics is a biopharmaceutical company that is committed to developing gene therapies for cancers, degenerative diseases and other cancer indications.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
